Traders Buy SPDR S&P Biotech ETF (XBI) on Weakness

Traders purchased shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) on weakness during trading hours on Wednesday. $107.62 million flowed into the stock on the tick-up and $67.42 million flowed out of the stock on the tick-down, for a money net flow of $40.20 million into the stock. Of all companies tracked, SPDR S&P Biotech ETF had the 18th highest net in-flow for the day. SPDR S&P Biotech ETF traded down ($0.40) for the day and closed at $79.95

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Captrust Financial Advisors raised its stake in SPDR S&P Biotech ETF by 126.2% in the third quarter. Captrust Financial Advisors now owns 1,192 shares of the exchange traded fund’s stock valued at $103,000 after buying an additional 665 shares during the period. Ballentine Partners LLC bought a new stake in SPDR S&P Biotech ETF in the second quarter valued at approximately $121,000. National Planning Corp bought a new stake in SPDR S&P Biotech ETF in the second quarter valued at approximately $211,000. Bingham Osborn & Scarborough LLC bought a new stake in SPDR S&P Biotech ETF in the third quarter valued at approximately $216,000. Finally, Northstar Asset Management LLC bought a new stake in SPDR S&P Biotech ETF in the third quarter valued at approximately $217,000.

ILLEGAL ACTIVITY WARNING: This article was reported by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this article on another domain, it was copied illegally and republished in violation of United States and international trademark and copyright law. The correct version of this article can be read at https://www.chaffeybreeze.com/2017/12/07/traders-buy-spdr-sp-biotech-etf-xbi-on-weakness.html.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply